BACE2C antibody (AA 310-339)
Quick Overview for BACE2C antibody (AA 310-339) (ABIN3029795)
Target
Reactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 310-339
-
Purpose
- BACE2C Antibody
-
Purification
- Purified
-
Immunogen
- A portion of amino acids 310-339 from the human protein was used as the immunogen for this BACE2C antibody.
-
Isotype
- Ig Fraction
-
-
-
-
Application Notes
- Titration of the BACE2C antibody may be required due to differences in protocols and secondary/substrate sensitivity.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- In 1X PBS, pH 7.4, with 0.09 % sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Aliquot the BACE2C antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- BACE2C (BACE2 C) (beta-Site APP-Cleaving Enzyme 2 C (BACE2 C))
-
Alternative Name
- BACE2C
-
Background
- Amyloid-beta peptide aggregation is a signature of Alzheimer disease and a frequent complication of adult Down syndrome patients. Amyloid-beta is generated by proteolytic processing of the amyloid precursor protein (APP) by beta- and gamma-secretase at the N and C termini, respectively. Presenilin-1 is involved in the gamma-secretase activity. BACE is a transmembrane aspartyl protease with beta-secretase activity. BACE2, also termed ALP56 has 2 pepsin-like active centers, a signal sequence, a propeptide, and a long C-terminal extension including a transmembrane domain, with expression in a wide array of tissues. Northern blot analysis revealed low expression of 2.0- and 2.6-kb BACE2 transcripts in most fetal and adult tissues, with higher expression in adult colon, kidney, pancreas, placenta, prostate, stomach, and trachea. Low levels were also detected in brain, with somewhat higher expression in medulla and spinal cord. In situ hybridization analysis of rat brain found low-level BACE2 expression in contrast to BACE expression. The BACE2 expression pattern does not appear to be consistent with that of a beta-secretase. BACE2 has been mapped to 21q22.3, within the Down syndrome critical region.
-
UniProt
- Q9Y5Z0
Target
-